Published Date: 03 Jul 2024
A University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining the extent of prostate cancer than the current standard MRI for intermediate and high-risk cases.
Read Full News1.
Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant
2.
More People Than Previously Believed Have Schizophrenia.
3.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
4.
Radioactive ion beams successfully treat animal tumors in study
5.
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.
1.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
2.
Transformative Advances in Hematology in Daily Practice
3.
Modern Concepts in Oncology Across Clinical Settings
4.
Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options
5.
Pediatric Advances in Long-Term Survivorship Science for Childhood Cancer
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation